Cargando…
Optimizing RV lead position in RV cardiomyopathy: Are we there yet?
Autores principales: | Sharma, Apurva, Tandri, Harikrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450924/ https://www.ncbi.nlm.nih.gov/pubmed/30858054 http://dx.doi.org/10.1016/j.ipej.2019.03.003 |
Ejemplares similares
-
Evaluation of Rv0220, Rv2958c, Rv2994 and Rv3347c of Mycobacterium tuberculosis for serodiagnosis of tuberculosis
por: You, Xiaolong, et al.
Publicado: (2017) -
Investigation of the Rv3065, Rv2942, Rv1258c, Rv1410c, and Rv2459 efflux pump genes expression among multidrug-resistant Mycobacterium tuberculosis clinical isolates
por: Shahi, Fatemeh, et al.
Publicado: (2021) -
Rv2031c of Mycobacterium tuberculosis: a master regulator of Rv2028–Rv2031 (HspX) operon
por: Mushtaq, Khurram, et al.
Publicado: (2015) -
Does RV fibrosis have an effect on mortality in patients hypertrophic cardiomyopathy? An LV vs. RV national death index (NDI) study
por: Biederman, Robert W, et al.
Publicado: (2015) -
CMR RV size assessment should include RV to LV volume ratio
por: Altmayer, Stephan P, et al.
Publicado: (2015)